cefixime has been researched along with B. burgdorferi Infection in 3 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Excerpt | Relevance | Reference |
---|---|---|
"Two treatment regimens for disseminated Lyme borreliosis (mainly neurologic and musculoskeletal manifestations) were compared in a randomized trial." | 2.69 | Comparison of oral cefixime and intravenous ceftriaxone followed by oral amoxicillin in disseminated Lyme borreliosis. ( Nikoskelainen, J; Oksi, J; Viljanen, MK, 1998) |
"Lyme disease is a tickborne illness caused by the spirochete Borrelia burgdorferi." | 1.31 | Longterm decrease in the CD57 lymphocyte subset in a patient with chronic Lyme disease. ( Burrascano, J; Stricker, RB; Winger, E, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vartiovaara, I | 1 |
Oksi, J | 1 |
Nikoskelainen, J | 1 |
Viljanen, MK | 1 |
Stricker, RB | 1 |
Burrascano, J | 1 |
Winger, E | 1 |
1 trial available for cefixime and B. burgdorferi Infection
Article | Year |
---|---|
Comparison of oral cefixime and intravenous ceftriaxone followed by oral amoxicillin in disseminated Lyme borreliosis.
Topics: Administration, Oral; Adult; Amoxicillin; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Drug Ad | 1998 |
2 other studies available for cefixime and B. burgdorferi Infection
Article | Year |
---|---|
Living with Lyme.
Topics: Adaptation, Psychological; Adult; Anti-Infective Agents; Azithromycin; Cefixime; Cefotaxime; Ceftria | 1995 |
Longterm decrease in the CD57 lymphocyte subset in a patient with chronic Lyme disease.
Topics: Adult; Anti-Bacterial Agents; CD57 Antigens; Cefixime; Chronic Disease; Clarithromycin; Female; Huma | 2002 |